Anixa Biosciences ANIX
NASDAQ ANIX
$2.77 -0.16 (-5.46%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) EV to EBITDA (2015 - 2016)

Updated

Anixa Biosciences' EV to EBITDA came in at 38.99 for fiscal Q3 2016 (quarter ended Jul 31, 2016).

Analysis

Anixa Biosciences (ANIX) EV to EBITDA (2015 - 2016) Analysis & Trends

  • The fiscal Q3 2016 figure represents the highest quarterly EV to EBITDA since fiscal Q1 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Anixa Biosciences 101.33 Mn 100.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2016 38.99
Jan 31, 2015 39.20
API Access

Anixa Biosciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ANIX&period=max&api_key=YOUR_API_KEY